Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice

Nat Genet. 2002 Sep;32(1):116-27. doi: 10.1038/ng954. Epub 2002 Aug 26.

Abstract

Williams syndrome is a neurodevelopmental disorder caused by the hemizygous deletion of 1.6 Mb on human chromosome 7q11.23. This region comprises the gene CYLN2, encoding CLIP-115, a microtubule-binding protein of 115 kD. Using a gene-targeting approach, we provide evidence that mice with haploinsufficiency for Cyln2 have features reminiscent of Williams syndrome, including mild growth deficiency, brain abnormalities, hippocampal dysfunction and particular deficits in motor coordination. Absence of CLIP-115 also leads to increased levels of CLIP-170 (a closely related cytoplasmic linker protein) and dynactin at the tips of growing microtubules. This protein redistribution may affect dynein motor regulation and, together with the loss of CLIP-115-specific functions, underlie neurological alterations in Williams syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / abnormalities
  • Dynactin Complex
  • Dyneins / metabolism
  • Gene Targeting
  • Heterozygote
  • Mice
  • Mice, Knockout
  • Microtubule-Associated Proteins / deficiency
  • Microtubule-Associated Proteins / genetics*
  • Microtubule-Associated Proteins / metabolism
  • Motor Activity
  • Mutagenesis, Site-Directed
  • Neoplasm Proteins
  • Nerve Tissue Proteins / deficiency
  • Nerve Tissue Proteins / genetics*
  • Phenotype
  • Williams Syndrome / genetics*
  • Williams Syndrome / physiopathology

Substances

  • Dynactin Complex
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • Nerve Tissue Proteins
  • cytoplasmic linker protein 115
  • cytoplasmic linker protein 170
  • Dyneins